Evidence map›Paper›PMID 26667227›Full record

ArticleInternational journal of immunopathology and pharmacology2016

Labeling quality and molecular characterization studies of products containing Lactobacillus spp. strains.

Giovanna Blandino, Davide Fazio, Giulio Petronio Petronio, Rosanna Inturri, Gianna Tempera, Pio Maria Furneri

Abstract readLetter
In one paragraph

Article in International journal of immunopathology and pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Characterization ofMicroorganisms · 2022
    Article
  4. Review
  5. Article
  6. Heliyon · 2019
    Article
  7. Status of microbial based cleaning products in statutory regulations and ecolabelling in Europe, the USA, and Canada.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giovanna BlandinoDipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Microbiologia, Università degli Studi di Catania, Catania, Italy.
Davide FazioDipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Microbiologia, Università degli Studi di Catania, Catania, Italy.
Giulio Petronio PetronioDipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Microbiologia, Università degli Studi di Catania, Catania, Italy IRCCS San Raffaele Pisana, BioBIM - Multidisciplinary Interinstitutional BioBank, Rome, Italy.
Rosanna InturriDipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Microbiologia, Università degli Studi di Catania, Catania, Italy.
Gianna TemperaDipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Microbiologia, Università degli Studi di Catania, Catania, Italy.
Pio Maria FurneriDipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Microbiologia, Università degli Studi di Catania, Catania, Italy furneri@unict.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the study was to characterize at species level by phenotypic and different molecular methods the strains of Lactobacillus spp. used as constituents of five oral and four vaginal products. Susceptibilities to representative antibiotics were evaluated. In addition, total viable counts at mid and 3 months to deadline of shelf life, in the different formulations and the presence of eventual contaminant microorganisms were investigated.In all oral products the molecular characterization at species level of the strains of Lactobacillus spp. confirmed the strains stated on the label, except for one strain cited on the label as Lactobacillus casei, that our study characterized as Lactobacillus paracasei. In oral products total viable cell content complied with content claimed on the label. In three out four vaginal products (one product claimed "bacillo di Döderlein"), molecular characterization complied with the bacterial name stated on the label. Two vaginal products reported viable counts on the label that were confirmed by our study. The other vaginal products, which did not report bacterial counts on the label, showed a similar decrease of viable counts at different dates to deadline compared to the others. From all the tested products, contaminant microorganisms and acquired resistance to representative antibiotics by the probiotic strains were not detected.

Indexed as

ProbioticsBacterial LoadDrug Resistance, BacterialFood MicrobiologyLactobacillusMicrobial Sensitivity Testslabel qualityLactobacillus spp.molecular characterizationoral and vaginal products

Identifiers

PMID26667227
PMCPMC5806746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.